SYMPOSIUM INFORMATION

>General Information
>Faculty
>Program/Schedule
>Accreditation - CME
>Registration
>Hotel Information



Officially Endorsed by:

UCSD Sulpizio Cardiovascular Center



The Heart Failure Society of America



American College of Cardiology



Arizona Chapter
California Chapter
Hawaii Chapter



The 7th  Annual
International Hawaii Symposium on
Diagnostic and Therapeutic Modalities in Heart Failure
A Comprehensive and Practical Review of Advances in
Heart Failure and Biomarkers


November 30 - December 2, 2017

Mauna Lani Bay Hotel and Bungalows
Kohala Coast, Island of Hawaii

>Download Symposium Brochure

PROGRAM / SCHEDULE

Thursday, November 30, 2017

7:00am
Registration Opens

7:15-8:15
Continental Breakfast

SESSION I
Heart Failure Prevention

Barry Greenberg, MD (Moderator)

8:15-8:35
Treating Hypertension in 2017 - After SPRINT What Makes the Most Sense?
Daniel Blanchard, MD

8:35-8:55
Can Treating Diabetes with SGLT2 Inhibitors Prevent Heart Failure?
Gregg Fonarow, MD

8:55-9:15
Results of Recent Trials with PCSK9 Inhibitors
Lori Daniels, MD

9:15-9:35
Cardiac Rehabilitation for Heart Failure Patients - Why, Who and How?
Pam Taub, MD

9:35-10:10
Case Presentation and Questions
Pam Taub, MD (Presenter), Drs. Blanchard, Fonarow, Daniels, Greenberg and Paul Hansen, PharmD (Panelists)

10:10-10:35 Break/Visit Exhibits

SESSION II
Biomarkers/HFpEF/NOACs
Alan Maisel, MD (Moderator)

10:35-10:55
Biomarkers I: Defining the Value of Measuring
Alan Maisel, MD

10:55-11:20
HFpEF - Unraveling the Causes and Finding New Treatments
Barry Greenberg, MD

11:20-11:40
The Use of NOACs in Cardiovascular Disease -
New Information, New Approaches
Lori Daniels, MD

11:40-12:10
Biomarkers II: Novel and Emerging Biomarkers
Alan Maisel, MD

12:10-1:15    Lunch - Product Theatre (Non-CME)
Repatha® (evolocumab): A Focused Clinical Review
Pam Taub, MD
Support Provided by Amgen

SESSION III
New Modalities of Heart Failure Therapy
John Chin, MD (Moderator)

4:00-4:20 Why and How to Use Combined Neprilysin and
Angiotensin Inhibition (ARNI) Therapy
Gregg Fonarow, MD

4:20-4:40
Value of SHIFTing to a Lower Heart Rate with Ivabradine
Uri Elkayam, MD

4:40-5:00
Treating Hyperkalemia-Why and How
James Fang, MD

5:00-5:25
New and Emerging Heart Failure Drugs
Barry Greenberg, MD

5:25-5:45
Natroceuticals and other OTC Drugs
Paul Hansen, Pharm D

5:45-6:10
Audience Questions - John Chin, MD (Moderator)
Drs. Fonarow, Greenberg, Elkayam, Fang and Paul Hansen, PharmD (Panelists)

6:10 Adjourn

Friday, December 1, 2017

7:00am Registration Opens

7:15-8:15    Breakfast - Product Theatre (Non-CME)
Thrombosis: AFib an Exploration in Risk Reduction
Uri Elkayam, MD
Support Provided by Janssen

SESSION IV
Pulmonary HTN, Sleep Apnea and CAD
Eric Adler, MD (Moderator)

8:15-8:40
Pulmonary Artery Hypertension I: Diagnosis and Classification
James Fang, MD

8:40-9:00
Diagnosing and Treating Sleep Apnea
Alan Maisel, MD

9:00-9:20
Wearables and Implantables for Our Patients
Pam Taub, MD

9:20-9:40
Pulmonary Artery Hypertension II: New and Emerging Therapies
James Fang, MD

9:40-10:10
Case Discussion - Dr. Fang (Presenter)
Drs. Taub, Maisel, Chin and Greenberg (Discussants)

10:10-10:30 Break/Visit Exhibits

SESSION V
Rhythm and Exercise
Uri Elkayam, MD (Moderator)

10:30-10:55
Optimizing the Management of Atrial Fibrillation Including Atrial Closure Devices
David Krummen, MD

10:55-11:20
Role of the Wearable Cardioverter Defibrillator (WCD)
Barry Greenberg, MD

11:20-11:45
Advances in CRT: What is the Impact for the
Patient with Heart Failure?
David Krummen, MD

11:45-12:10 New Pacing Approaches and Strategies
David Singh, MD

12:10-12:25
Panel Discussion and Audience Questions
Dr. Elkayam (Moderator), Drs. Krummen, Greenberg and Singh (Panelists)

12:25-1:30    Lunch - Product Theatre (Non-CME)
Optimizing Treatment to Improve Outcomes: Implementing the New Guideline for Managing Heart Failure With Reduced Ejection Fraction
Barry Greenberg, MD
Support Provided by Novartis Pharmaceuticals Corporation

SESSION VI
Practical Approaches to Acute Heart Failure and Transitions of Care
Gregg Fonarow, MD (Moderator)

4:00-4:35
Management Strategies for Acute Heart Failure
Barry Greenberg, MD

4:35-5:00
Temporary Percutaneous Circulatory Support
Eric Adler, MD

5:00-5:35
Optimizing Transitions of Care
Nancy Albert, PhD

5:35-6:00
Remote Monitoring of Pulmonary Artery Pressures
Gregg Fonarow, MD

Saturday, December 2, 2017

7:00am
Registration Opens

7:15-8:15    Breakfast - Product Theatre (Non-CME)
High Sensitive Troponins – There are NO False Positives
Alan Maisel, MD and Robin J. Trupp, PhD, RN
Support Provided by Roche Diagnostics

SESSION VII
Advances in Managing End-Stage Heart Failure
Barry Greenberg, MD (Moderator)

8:15-8:40
Defining End-Stage Heart Failure
Eric Adler, MD

8:40-9:05
Role of Palliative Care and Hospice
Nancy Albert, PhD

9:05-9:30
Transplant and VADs
Eric Adler, MD

9:30-9:50
Managing Hyponatremia
John Chin, MD

9:50-10:15
Questions/Case Presentation - Dr. Adler (Presenter)
Drs. Greenberg, Elkayam, Fang and Albert (Discussants)

10:15-10:40
Break/Visit Exhibits

SESSION VIII
Topics in Heart Failure
Alan Maisel, MD (Moderator)

10:40-11:05
Treatment with Hydralazine and Nitrates
Uri Elkayam, MD

11:05-11:30
Let’s Not Forget about Cardiac Ausculatation:
New Advances in the Stethoscope
Alan Maisel, MD

11:30-12:00
3rd Annual Echo Imaging Quiz - Fascinomas Included at No Extra Charge
Daniel Blanchard, MD

12:00
Meeting adjourned until December 2018!